rs5883
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_000078.3(CETP):c.861C>T(p.Phe287Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0536 in 1,614,184 control chromosomes in the GnomAD database, including 2,687 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.065 ( 399 hom., cov: 32)
Exomes 𝑓: 0.052 ( 2288 hom. )
Consequence
CETP
NM_000078.3 synonymous
NM_000078.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.649
Genes affected
CETP (HGNC:1869): (cholesteryl ester transfer protein) The protein encoded by this gene is found in plasma, where it is involved in the transfer of cholesteryl ester from high density lipoprotein (HDL) to other lipoproteins. Defects in this gene are a cause of hyperalphalipoproteinemia 1 (HALP1). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 16-56973441-C-T is Benign according to our data. Variant chr16-56973441-C-T is described in ClinVar as [Benign]. Clinvar id is 319984.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-56973441-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.649 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.103 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CETP | NM_000078.3 | c.861C>T | p.Phe287Phe | synonymous_variant | 9/16 | ENST00000200676.8 | NP_000069.2 | |
CETP | NM_001286085.2 | c.750+1358C>T | intron_variant | NP_001273014.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CETP | ENST00000200676.8 | c.861C>T | p.Phe287Phe | synonymous_variant | 9/16 | 1 | NM_000078.3 | ENSP00000200676.3 | ||
CETP | ENST00000379780.6 | c.750+1358C>T | intron_variant | 1 | ENSP00000369106.2 | |||||
CETP | ENST00000566128.1 | c.666C>T | p.Phe222Phe | synonymous_variant | 9/16 | 5 | ENSP00000456276.1 |
Frequencies
GnomAD3 genomes AF: 0.0648 AC: 9861AN: 152190Hom.: 399 Cov.: 32
GnomAD3 genomes
AF:
AC:
9861
AN:
152190
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0513 AC: 12897AN: 251464Hom.: 417 AF XY: 0.0500 AC XY: 6796AN XY: 135908
GnomAD3 exomes
AF:
AC:
12897
AN:
251464
Hom.:
AF XY:
AC XY:
6796
AN XY:
135908
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0525 AC: 76707AN: 1461876Hom.: 2288 Cov.: 33 AF XY: 0.0520 AC XY: 37795AN XY: 727244
GnomAD4 exome
AF:
AC:
76707
AN:
1461876
Hom.:
Cov.:
33
AF XY:
AC XY:
37795
AN XY:
727244
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0648 AC: 9864AN: 152308Hom.: 399 Cov.: 32 AF XY: 0.0611 AC XY: 4554AN XY: 74486
GnomAD4 genome
AF:
AC:
9864
AN:
152308
Hom.:
Cov.:
32
AF XY:
AC XY:
4554
AN XY:
74486
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
89
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 17, 2018 | This variant is associated with the following publications: (PMID: 28008009, 22403620, 24393849) - |
Hyperalphalipoproteinemia 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at